United Therapeutics Corporation (UTHR)
Gross profit margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Gross profit | US$ in thousands | 2,567,700 | 2,070,000 | 1,789,600 | 1,563,000 | 1,375,200 |
| Revenue | US$ in thousands | 2,877,400 | 2,327,500 | 1,936,300 | 1,685,500 | 1,483,300 |
| Gross profit margin | 89.24% | 88.94% | 92.42% | 92.73% | 92.71% |
December 31, 2024 calculation
Gross profit margin = Gross profit ÷ Revenue
= $2,567,700K ÷ $2,877,400K
= 89.24%
United Therapeutics Corporation's gross profit margin has remained relatively stable over the years, starting at a high of 92.71% on December 31, 2020, slightly increasing to 92.73% by December 31, 2021, and then experiencing a slight decline to 92.42% by December 31, 2022. However, there was a more noticeable decrease to 88.94% by December 31, 2023, followed by a modest increase to 89.24% by December 31, 2024.
Overall, the trend in the gross profit margin indicates that the company has been able to maintain high levels of profitability relative to its cost of goods sold, although there was a dip in 2023. It's important for United Therapeutics Corporation to continue monitoring and managing its cost structure effectively to ensure sustained profitability and competitive positioning in the market.
Peer comparison
Dec 31, 2024